Details for New Drug Application (NDA): 062736
✉ Email this page to a colleague
NDA 062736 describes BACTOCILL, which is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in six NDAs. Additional details are available on the BACTOCILL profile page.
The generic ingredient in BACTOCILL is oxacillin sodium. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
The generic ingredient in BACTOCILL is oxacillin sodium. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
Summary for 062736
| Tradename: | BACTOCILL |
| Applicant: | Glaxosmithkline |
| Ingredient: | oxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062736
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 19, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 19, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
